 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || fluticasone propionate inhalation powder / Generic mfg.
New P1 trial: A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS (clinicaltrials.gov) - May 30, 2022
P1, N=36, Active, not recruiting, Sponsor: Respirent Pharmaceuticals Co Ltd.
- | Onbrez (indacaterol) / Novartis
Journal: Using Filters to Estimate Regional Lung Deposition with Dry Powder Inhalers. (Pubmed Central) - Feb 4, 2022
Because of its design, the TB filter apparatus makes it possible to estimate regional deposition with inhalers directly using variable inhalation profiles without any additional equipment or changes to the experimental configuration. This method may be useful to expedite development of both innovative and generic drug products as it provides regional respiratory tract deposition estimates using fewer resources than exisiting methods.
- || fluticasone propionate inhalation powder / Generic mfg.
New P1 trial: A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS (clinicaltrials.gov) - Aug 25, 2021
P1, N=50, Recruiting, Sponsor: Respirent Pharmaceuticals Co Ltd.
- |||||| fluticasone propionate inhalation powder / Generic mfg.
Enrollment open: ANASSA-PD: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma (clinicaltrials.gov) - Jan 20, 2021
P3, N=451, Recruiting, Sponsor: Respirent Pharmaceuticals Co Ltd.
This method may be useful to expedite development of both innovative and generic drug products as it provides regional respiratory tract deposition estimates using fewer resources than exisiting methods. Not yet recruiting --> Recruiting
- |||||||||| fluticasone propionate inhalation powder / Generic mfg.
New P3 trial: ANASSA-PD: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma (clinicaltrials.gov) - Dec 14, 2020
P3, N=451, Not yet recruiting, Sponsor: Respirent Pharmaceuticals Co Ltd.
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Trial completion: ECATCh: Environmental Control as Add-on Therapy in Childhood Asthma (clinicaltrials.gov) - Dec 20, 2018
P2, N=155, Completed, Sponsor: Johns Hopkins University
Not yet recruiting --> Recruiting Recruiting --> Completed
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Enrollment change: MICT: Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial (clinicaltrials.gov) - Apr 18, 2018
P4, N=108, Completed, Sponsor: Nemours Children's Clinic
Recruiting --> Completed N=71 --> 108
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Trial completion: BARD: Best African American Response to Asthma Drugs (clinicaltrials.gov) - Jul 26, 2017
P3, N=574, Completed, Sponsor: Milton S. Hershey Medical Center
N=71 --> 108 Active, not recruiting --> Completed
- ||| Armonair Respiclick (fluticasone propionate MDPI) / Teva
Enrollment change: A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications (clinicaltrials.gov) - May 31, 2017
P2, N=889, Completed, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Active, not recruiting --> Completed N=622 --> 889
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Trial completion, Enrollment change: MICT: Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial (clinicaltrials.gov) - Mar 29, 2017
P4, N=71, Completed, Sponsor: Nemours Children's Clinic
N=622 --> 889 Enrolling by invitation --> Completed | N=180 --> 71
- ||||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
New P4 trial: Study of ADVAIR DISKUS and FLOVENT DISKUS taken twice daily in children during fall viral season. (EUDRACT) - Jan 20, 2017
P4, N=339, , Sponsor: GlaxoSmithKline Research & Development Ltd
- Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
Trial completion, Enrollment change, Trial primary completion date: Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth (clinicaltrials.gov) - Jul 24, 2016
P4, N=32, Completed, Sponsor: West Penn Allegheny Health System
Enrolling by invitation --> Completed | N=180 --> 71 Recruiting --> Completed | N=60 --> 32 | Trial primary completion date: Dec 2014 --> Feb 2016
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Enrollment change, Trial primary completion date: MICT: Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial (clinicaltrials.gov) - Jun 10, 2016
P4, N=180, Enrolling by invitation, Sponsor: Nemours Children's Clinic
Recruiting --> Completed | N=60 --> 32 | Trial primary completion date: Dec 2014 --> Feb 2016 N=120 --> 180 | Trial primary completion date: Aug 2016 --> Feb 2017
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Enrollment closed, Trial primary completion date: BARD: Best African American Response to Asthma Drugs (clinicaltrials.gov) - Apr 15, 2016
P3, N=544, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
N=120 --> 180 | Trial primary completion date: Aug 2016 --> Feb 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2017
- | Armonair Respiclick (fluticasone propionate MDPI) / Teva
Trial completion: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older (clinicaltrials.gov) - Oct 7, 2015
P1, N=43, Completed, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2017 Active, not recruiting --> Completed
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Enrollment open, Trial primary completion date: ECATCh: Environmental Control as Add-on Therapy in Childhood Asthma (clinicaltrials.gov) - Sep 9, 2015
P2, N=200, Recruiting, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Oct 2017 --> Oct 2018
- Armonair Respiclick (fluticasone propionate MDPI) / Teva
Enrollment closed: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older (clinicaltrials.gov) - Aug 24, 2015
P1, N=40, Active, not recruiting, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting --> Recruiting | Trial primary completion date: Oct 2017 --> Oct 2018 Recruiting --> Active, not recruiting
- Armonair Respiclick (fluticasone propionate MDPI) / Teva
Enrollment open: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older (clinicaltrials.gov) - Jul 10, 2015
P1, N=40, Recruiting, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Armonair Respiclick (fluticasone propionate MDPI) / Teva
New P1 trial: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older (clinicaltrials.gov) - May 7, 2015
P1, N=40, Not yet recruiting, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Trial primary completion date: BARD: Best African American Response to Asthma Drugs (clinicaltrials.gov) - Apr 23, 2015
P3, N=544, Recruiting, Sponsor: Milton S. Hershey Medical Center
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2016 --> Mar 2017
- Advair HFA (salmeterol xinafoate/fluticasone propionate inhalation aerosol) / GSK
Trial completion, Trial primary completion date: WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects (clinicaltrials.gov) - Mar 11, 2015
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Jun 2016 --> Mar 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2013
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion, Trial primary completion date: Dose-Response of Salmeterol in Children (clinicaltrials.gov) - Oct 11, 2014
P4, N=10, Completed, Sponsor: University of Florida
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2013 Recruiting --> Completed | Trial primary completion date: Aug 2014 --> May 2014
- ||||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
New P2 trial: ECATCh: Environmental Control as Add-on Therapy in Childhood Asthma (clinicaltrials.gov) - Sep 29, 2014
P2, N=200, Not yet recruiting, Sponsor: Johns Hopkins University
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Enrollment open: Dose-Response of Salmeterol in Children (clinicaltrials.gov) - Feb 26, 2014
P4, N=10, Recruiting, Sponsor: University of Florida
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> May 2014 Not yet recruiting --> Recruiting
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
New P4 trial: MICT: Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial (clinicaltrials.gov) - Feb 10, 2014
P4, N=120, Enrolling by invitation, Sponsor: Nemours Children's Clinic
- | fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Enrollment open: BARD: Best African American Response to Asthma Drugs (clinicaltrials.gov) - Feb 9, 2014
P3, N=494, Recruiting, Sponsor: Milton S. Hershey Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||| fluticasone propionate inhalation powder / Generic mfg.
Trial completion: A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids (clinicaltrials.gov) - Nov 17, 2013
P2, N=622, Completed, Sponsor: Teva Pharmaceutical Industries
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||| Armonair Respiclick (fluticasone propionate MDPI) / Teva
Trial completion: A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications (clinicaltrials.gov) - Nov 17, 2013
P2, N=622, Completed, Sponsor: Teva Pharmaceutical Industries
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
New P3 trial: BARD: Best African American Response to Asthma Drugs (clinicaltrials.gov) - Oct 20, 2013
P3, N=494, Recruiting, Sponsor: Milton S. Hershey Medical Center
- fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
New P4 trial: Dose-Response of Salmeterol in Children (clinicaltrials.gov) - Jul 22, 2013
P4, N=10, Recruiting, Sponsor: University of Florida
- fluticasone propionate inhalation powder / Generic mfg.
Enrollment change: MethaCholine Bronchoprovocation Study (MeCIS) (clinicaltrials.gov) - Feb 10, 2013
P4, N=219, Completed, Sponsor: Johns Hopkins Bloomberg School of Public Health
Active, not recruiting --> Completed N=140 --> 219
- Advair HFA (salmeterol xinafoate/fluticasone propionate inhalation aerosol) / GSK
Clinical: WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects (clinicaltrials.gov) - Jan 7, 2013
P=N/A, N=1, Active, not recruiting, Sponsor: GlaxoSmithKline
- ||||| Armonair Respiclick (fluticasone propionate MDPI) / Teva
New P2 trial: A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications (clinicaltrials.gov) - Apr 10, 2012
P2, N=622, Completed, Sponsor: Teva Pharmaceutical Industries
- Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
Enrollment open: Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth (clinicaltrials.gov) - Feb 19, 2012
P4, N=60, Recruiting, Sponsor: West Penn Allegheny Health System
N=140 --> 219 Not yet recruiting --> Recruiting
- | Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
New P4 trial: Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth (clinicaltrials.gov) - Jan 26, 2012
P4, N=60, Recruiting, Sponsor: West Penn Allegheny Health System
- | montelukast / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg., fluticasone propionate inhalation powder / Generic mfg.
Trial completion: Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) (clinicaltrials.gov) - Dec 28, 2011
P3, N=182, Completed, Sponsor: Milton S. Hershey Medical Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| fluticasone propionate inhalation powder / Generic mfg.
New P2 trial: A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids (clinicaltrials.gov) - Nov 22, 2011
P2, N=622, Completed, Sponsor: Teva Pharmaceutical Industries
- Armonair Respiclick (fluticasone propionate MDPI) / Teva
Trial termination: Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients (clinicaltrials.gov) - Aug 25, 2011
P4, N=49, Terminated, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Active, not recruiting --> Completed Completed --> Terminated; Very poor enrollment